mirtazapine has been researched along with Leukopenia in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Leukopenia: A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dholakia, R | 1 |
| Schleifer, SJ | 1 |
| Ahmad, YJ | 1 |
| Narang, IS | 1 |
| Anghelescu, I | 1 |
| Klawe, C | 1 |
| Dahmen, N | 1 |
2 other studies available for mirtazapine and Leukopenia
| Article | Year |
|---|---|
Delayed-onset mirtazapine-related leukopenia and rechallenge.
Topics: Adult; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Dysthymic Disorder; Femal | 2010 |
Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia.
Topics: Agranulocytosis; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbi | 2002 |